N,N'-二(氨基亚胺甲基)-4-O-[2-O-(2-脱氧-2-甲基氨基-alpha-L-吡喃葡萄糖基)-3-C-甲酰基-alpha-L-来苏呋喃糖基]-D-链霉胺 | 6835-00-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: N,N'-二(氨基亚胺甲基)-4-O-[2-O-(2-脱氧-2-甲基氨基-alpha-L-吡喃葡萄糖基)-3-C-甲酰基-alpha-L-来苏呋喃糖基]-D-链霉胺
• 英文名称: Hydroxystreptomycin
• 英文别名: 2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine
• CAS: 6835-00-3
• 化学式: C₂₁H₃₉N₇O₁₃
• 分子量: 597.6
• InChiKey: OFNXOACBUMGOPC-HZYVHMACSA-N

物化性质

• 沸点：
  918.7±75.0 °C(Predicted)
• 密度：
  2.04±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -8.5
• 重原子数：
  41
• 可旋转键数：
  10
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  357
• 氢给体数：
  13
• 氢受体数：
  16

文献信息

• PHOSPHONIUM ION CHANNEL BLOCKERS AND METHODS FOR USE
  申请人：Nocion Therapeutics, Inc.

  公开号：US20210128589A1

  公开（公告）日：2021-05-06

  The invention provides compounds of Formula (I), or pharmaceutically acceptable salts thereof: The compounds, compositions, methods and kits of the invention are useful for the treatment of pain, itch, and neurogenic inflammation.

  本发明提供了式(I)的化合物，或其药用可接受的盐： 本发明的化合物、组合物、方法和试剂盒可用于治疗疼痛、瘙痒和神经性炎症。
• METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIISOCYANATE
  申请人：Warsaw Orthopedic, Inc.

  公开号：US20150197488A1

  公开（公告）日：2015-07-16

  A method of making an amino acid triisocyanate is provided, the method comprising reacting an amino acid trihydrochloride with phosgene to form the amino acid triisocyanate. In some embodiments, the amino acid trihydrochloride comprises lysine ester trihydrochloride salt and the amino acid triisocyanate comprises lysine ester triisocyanate. In some embodiments, there is a lysine ester triisocyanate having a purity of at least about 98%, the lysine ester triisocyanate having a structure resulting from reacting lysine ester trihydrochloride salt with phosgene to form the lysine ester triisocyanate. These lysine ester triisocyanates can be used to make biodegradable polyurethanes.

  提供了一种制备氨基酸三异氰酸酯的方法，该方法包括将氨基酸三氢氯酸盐与光气反应以形成氨基酸三异氰酸酯。在一些实施例中，氨基酸三氢氯酸盐包括赖氨酸酯三氢氯酸盐，而氨基酸三异氰酸酯包括赖氨酸酯三异氰酸酯。在一些实施例中，存在一种纯度至少约为98%的赖氨酸酯三异氰酸酯，该赖氨酸酯三异氰酸酯具有由赖氨酸酯三氢氯酸盐与光气反应形成赖氨酸酯三异氰酸酯的结构。这些赖氨酸酯三异氰酸酯可用于制造生物降解聚氨酯。
• [EN] CARBAZOLE AND CARBOLINE KINASE INHIBITORS<br/>[FR] CARBAZOLE ET INHIBITEURS DE LA CARBOLINE KINASE
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2010080474A1

  公开（公告）日：2010-07-15

  The present invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The Formula (I) compounds inhibit tyrosine kinase activity of Jak2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.

  本发明提供了式（I）的化合物及其药用可接受的盐。式（I）的化合物抑制Jak2的酪氨酸激酶活性，因此使它们在作为抗增殖剂治疗癌症和其他疾病方面有用。
• METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIHYDROCHLORIDE
  申请人：Warsaw Orthopedic, Inc.

  公开号：US20150197483A1

  公开（公告）日：2015-07-16

  In some embodiments, a method of making an amino acid trihydrochloride is provided, the method comprising reacting an amino acid monohydrochloride with an alkanolamine to form the amino acid trihydrochloride. In some embodiments, the amino acid monohydrochloride comprises lysine hydrochloride, which is mixed with ethanolamine to form lysine ester trihydrochloride. In some embodiments, there is a lysine ester trihydrochloride salt having a purity of at least about 98%, the lysine ester trihydrochloride salt having a structure resulting from reacting lysine hydrochloride and ethanolamine to form the lysine ester trihydrochloride salt. The lysine ester trihydrochloride can be made in one reaction vessel.

  在某些实施例中，提供了一种制备氨基酸三氢氯化物的方法，该方法包括将氨基酸单氢氯化物与烷醇胺反应以形成氨基酸三氢氯化物。在某些实施例中，氨基酸单氢氯化物包括赖氨酸盐酸盐，其与乙醇胺混合以形成赖氨酸酯三氢氯化物。在某些实施例中，存在一种纯度至少约98%的赖氨酸酯三氢氯化物盐，该赖氨酸酯三氢氯化物盐具有由赖氨酸盐酸盐和乙醇胺反应形成赖氨酸酯三氢氯化物盐的结构。赖氨酸酯三氢氯化物可以在一个反应容器中制造。
• [EN] JAK2 INHIBITORS AND THEIR USE FOR THE TREATMENT OF MYELOPROLIFERATIVE DISEASES AND CANCER<br/>[FR] INHIBITEURS DE JAK2 ET LEUR UTILISATION POUR LE TRAITEMENT DE MALADIES MYÉLOPROLIFÉRATIVES ET DU CANCER
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2011028864A1

  公开（公告）日：2011-03-10

  The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The formula (I) compounds inhibit tyrosine kinase activity of JAK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.

  本发明提供了式（I）的化合物及其药学上可接受的盐。式（I）的化合物抑制JAK2的酪氨酸激酶活性，因此使它们在作为抗增殖剂治疗癌症和其他疾病时具有用途。